01.08.2018 17:40:51
|
NEURONES: Organic growth up 5.1% in 1st half 2018
PRESS INFORMATION
Nanterre, August 1, 2018 (after trading)
Heading: Revenues H1 2018
Organic growth up 5.1% in 1st half 2018
(in millions of euros) | H1 2017 restated IFRS15 (*) | H1 2018 IFRS15 (*) | growth | of which organic |
Revenues | 239.2 | 243.1 | + 1.6% | + 5.1% |
Achievements
With constant structures and similar accounting method (IFRS15), organic growth is up 5.1% for the first six months of 2018.
The operating profit for the half-year is 8.5% of revenues (**), compared with 8.6% for the first half of 2017.
In comparison with the 2017 reference document available in the Finance section on the Neurones website (www.neurones.net, "Finance" page), there were no significant changes in the financial situation.
Outlook
With constant structures, NEURONES forecasts the following for 2018:
- close to €490m in revenues (IFRS15*),
- an operating profit of approximately 9% of revenues.
(*) Application of IFRS15 reduced the group's revenues by around €9 million in 2017 and 2018, naturally with no impact on operating profit.
(**) Unaudited and after inclusion of 0.3% expenses related to bonus shares.
About NEURONES
With over 5,100 employees, the NEURONES group specializes in Consulting (Management, Organization and Digital) and IT Services (Infrastructures and Applications). It supports its clients in their digital transformation and information system outsourcing projects.
Euronext Paris (compartment B - NRO) - Enternext Tech 40 - SRD medium values
Press Relations: Florence Gillier Communication Sabine GROSDIDIER +33 1 41 18 85 55 sabineg@fgcom.fr | NEURONES Matthieu VAUTIER +33 1 41 37 41 37 rp@neurones.net |
Investor Relations: NEURONES Paul-César BONNEL +33 1 41 37 41 37 investisseurs@neurones.net |
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NEURONES via Globenewswire
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu NeuronesAct.mehr Nachrichten
Keine Nachrichten verfügbar. |